Roles of Macrophages in Atherogenesis

Lia Farahi1, Satyesh K Sinha2, Aldons J Lusis2

  • 1Monoclonal Antibody Research Center, Avicenna Research Institute, Tehran, Iran.

Frontiers in Pharmacology
|December 13, 2021
PubMed

Insights

Macrophages play a key role in atherosclerosis, a chronic inflammatory disease. Understanding macrophage functions and heterogeneity is crucial for developing novel atherosclerosis therapies.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Cell Biology

Background:

  • Atherosclerosis is a chronic inflammatory disease leading to plaque rupture, myocardial infarction, stroke, and sudden cardiac death.
  • Monocytes differentiate into macrophages in the arterial wall, contributing to plaque formation and regression.
  • Macrophages engulf lipoproteins, becoming foam cells, and their phenotype is influenced by various stimuli.

Purpose of the Study:

  • To review recent advances in understanding the roles of macrophages in atherosclerosis pathogenesis.
  • To discuss the heterogeneity of macrophages in atherosclerotic lesions.
  • To describe macrophage-based therapies for atherosclerosis management.

Main Methods:

  • Review of recent scientific literature on macrophage roles in atherosclerosis.
  • Analysis of findings from single-cell sequencing techniques addressing macrophage heterogeneity.
  • Synthesis of information on macrophage functions including polarization, efferocytosis, proliferation, and apoptosis.

Main Results:

  • Macrophages are central to all stages of atherosclerosis, from initiation to advanced disease.
  • Macrophage heterogeneity, revealed by single-cell sequencing, impacts disease progression.
  • Macrophage phenotype modulation influences key processes like foam cell formation and inflammation.

Conclusions:

  • Macrophages are critical players in atherosclerosis pathogenesis, influencing lesion development and stability.
  • Targeting macrophage functions and heterogeneity offers potential therapeutic strategies for atherosclerosis.
  • Further research into macrophage biology is essential for advancing atherosclerosis treatment.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
56.1K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
162
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
76
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
5.2K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
4.1K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
62